Insulin glargine (Lantus®)

Recommended for restricted use within the NHS Scotland.

REASONS FOR ADVICE

Insulin glargine is an acceptable treatment for patients with diabetes mellitus. Pending further studies, its use should be targeted on patients who are at risk or experience unacceptable frequency and/or severity of nocturnal hypoglycaemia on attempting to achieve better hypoglycaemic control during treatment with established insulins. It is also acceptable as a once daily insulin therapy for patients who require carer administration of their insulin. At present the evidence does not support its routine use in patients with type 2 diabetes unless they suffer from recurrent episodes of hypoglycemia or require assistance with their insulin injections.